MENU
+Compare
SMRI
ETF ticker: NASDAQ
AS OF
Aug 11, 12:03 PM (EDT)
Price
$31.88
Change
-$0.10 (-0.31%)
Net Assets
426.99M

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Large Value
SMRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SMRI with price predictions
Aug 08, 2025

SMRI in upward trend: price may jump up because it broke its lower Bollinger Band on August 01, 2025

SMRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 13 cases where SMRI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in of 129 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SMRI as a result. In of 23 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SMRI turned negative on July 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at .

SMRI moved below its 50-day moving average on July 31, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SMRI crossed bearishly below the 50-day moving average on August 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SMRI entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Exxon Mobil Corp (NYSE:XOM), Chevron Corp (NYSE:CVX), Merck & Co (NYSE:MRK), QUALCOMM (NASDAQ:QCOM), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), ConocoPhillips (NYSE:COP), Nike (NYSE:NKE), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF ETF is 62.7B. The market cap for tickers in the group ranges from 5.2B to 455.31B. XOM holds the highest valuation in this group at 455.31B. The lowest valued company is MRP at 5.2B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF ETF was 9%. For the same ETF, the average monthly price growth was 22%, and the average quarterly price growth was 50%. NEM experienced the highest price growth at 10%, while ON experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF ETF was -20%. For the same stocks of the ETF, the average monthly volume growth was 4% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 44
Price Growth Rating: 48
SMR Rating: 53
Profit Risk Rating: 54
Seasonality Score: -38 (-100 ... +100)
View a ticker or compare two or three
SMRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Fundamentals
Details
Category
Large Value
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com